|
End-of-day quote
Dhaka S.E.
05/11/2026
|
5-day change | 1st Jan Change | ||
| 25.60 BDT | +1.59% |
|
-9.54% | -6.57% |
| Market Cap | 6.69B 53.74M 47.89M 43.8M 39.89M 75.19M 5.08B 77.22M 526M 210M 2.69B 202M 197M 8.49B | P/E 2024 |
50.8x | P/E 2025 | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.23B 259M 231M 211M 192M 362M 24.46B 372M 2.53B 1.01B 12.95B 971M 951M 40.88B | EV / Sales 2024 |
3.62x | EV / Sales 2025 | 7.99x |
| Free-Float |
74.17% | Yield 2024 |
1.45% | Yield 2025 | - |
| 1 day | +1.59% | ||
| 1 week | -9.54% | ||
| Current month | -9.54% | ||
| 1 month | -5.88% | ||
| 3 months | -10.80% | ||
| 6 months | -3.76% | ||
| Current year | -6.57% |
| 1 week | 24.9 |  | 28.8 |
| 1 month | 24.9 | | 31.5 |
| Current year | 23.5 | | 33.2 |
| 1 year | 22.9 | | 33.2 |
| 3 years | 22.9 | | 91.8 |
| 5 years | 22.9 | | 156.5 |
| 10 years | 22.9 | | 156.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 48 | 01/01/2020 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 10/09/2014 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 01/01/1985 |
Hasina Begum
BRD | Director/Board Member | 68 | 01/01/1997 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.59% | -9.54% | -13.22% | -67.84% | 48.1M | |
| -0.26% | -3.82% | +45.45% | +129.08% | 1,216B | |
| -0.11% | -0.29% | +45.70% | +79.57% | 656B | |
| +0.15% | -1.99% | +31.95% | +104.68% | 509B | |
| -1.14% | -4.31% | +45.55% | +62.77% | 384B | |
| -0.45% | -1.91% | +70.98% | +40.56% | 362B | |
| -0.99% | -0.82% | +30.18% | +57.50% | 311B | |
| -1.02% | -0.53% | +8.20% | +35.13% | 293B | |
| +0.15% | -0.99% | +46.20% | +69.12% | 249B | |
| -0.13% | -1.78% | +35.85% | +106.61% | 208B | |
| Average | -0.22% | -0.08% | +34.68% | +61.72% | 418.78B | |
| Weighted average by Cap. | -0.34% | +0.03% | +41.89% | +88.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.62B 85.29M 76M 69.51M 63.31M 119M 8.06B 123M 835M 334M 4.27B 320M 313M 13.47B | 4.08B 32.78M 29.21M 26.72M 24.33M 45.86M 3.1B 47.1M 321M 128M 1.64B 123M 120M 5.18B |
| Net income | 318M 2.55M 2.28M 2.08M 1.9M 3.57M 241M 3.67M 25.01M 10M 128M 9.59M 9.38M 403M | -415M -3.33M -2.97M -2.72M -2.48M -4.67M -315M -4.79M -32.65M -13.06M -167M -12.52M -12.25M -527M |
| Net Debt | 22.31B 179M 160M 146M 133M 251M 16.93B 257M 1.75B 701M 8.96B 672M 658M 28.29B | 25.54B 205M 183M 167M 152M 287M 19.38B 295M 2.01B 803M 10.26B 770M 753M 32.39B |
Employees
2,954
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | BDT 25.60 | +1.59% | 850,707 |
| 04/11/26 | BDT 25.20 | -4.18% | 1,251,762 |
| 03/11/26 | BDT 26.30 | -1.50% | 644,729 |
| 02/11/26 | BDT 26.70 | -2.20% | 283,496 |
| 01/11/26 | BDT 27.30 | -3.53% | 485,298 |
- Stock Market
- Stocks
- ORIONPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
